Ethnobotany, phytochemistry, pharmacology, and conservation of the genus Calanthe R. Br. (Orchidaceae).

ETHNOPHARMACOLOGICAL RELEVANCE: The Genus Calanthe (family Orchidaceae) consists of more than 207 species distributed in both tropical and subtropical regions. In traditional medicine, Calanthe species provide remedies against various conditions such as arthritis, rheumatism, traumatic injuries, snake-bites, abdominal discomfort, nose bleeding, common colds, ulcers, chronic coughs, and others. Some species are also used as aphrodisiacs, tonics, and as pain relievers on joints and toothaches. AIM OF THE REVIEW: This review provides comprehensive information on the herbal uses, chemical components, pharmacological activities, and conservation of Calanthe, which might be useful in the future development of potent herbal medicines and facilitate the enactment of better conservation strategies. MATERIALS AND METHODS: Relevant information was obtained from online databases including SCI-Finder, Google Scholar, Web of Science, Science Direct, PubMed, Springer, IOP Science, and other web sources such as PubChem, The Plant List, and World Flora Online. Books, Ph.D. and MSc dissertations were used for unpublished literature. Information from Chinese literature was obtained from the CNKI database. RESULTS: In total, 19 species of the genus Calanthe have been reported to be used in traditional medicine in different countries of Asia. A total of 265 chemical compounds from different chemical classes including, alkaloids, terpenoids, phenolic compounds and phenolic derivatives, phenanthrenes, and others, have been identified from Calanthe species. Calanquinone A isolated from C. arisanensis has been reported to exhibit antitumor activity against six malignant cell lines. Other bioactive compounds from Calanthe with pharmacological activity include phenanthrenes, phenanthrenequinones, 6'-O-ß-D-apiofuranosylindican, 4H-Pyran-4one, 2, 3-dihydro-3,5 dihydroxy-6-methyl, and calanthoside. These compounds exhibit valuable biological properties such as hair restoration, anticancer activity, anti-inflammatory and antiarthritic activity, antidiabetic and hepatoprotective potency, antiplatelet aggregation action, and antibacterial and antifungal activities. Some Calanthe species, including C. ecallosa and C. yuana, are endangered in the IUCN red list. The high risk of extinction is attributed to illegal trade and unsustainable harvesting and utilization. CONCLUSIONS: This review summarizes the herbal uses, chemical components, biological activity, and conservation of Calanthe. The pharmacological studies on this genus are limited; thus, extensive research on the toxicology, pharmaceutical standardization, and mechanism of action of the isolated bioactive compounds are needed. Since some species of Calanthe are listed as endangered, stringent guidelines on trade, collection, and sustainable utilization of medicinal orchids should be set up to facilitate the conservation of these species.

Understanding the Ethnobotany, Chemistry, Pharmacology, and Distribution of Genus Hydnora (Aristolochiaceae).

The genus Hydnora (Hydnoraceae) is one of the basal angiosperms in the order Piperales, found in the semi-arid regions of Africa, and the Southern Arabian Peninsula. Plants in this genus play essential roles in communities around the world as revealed by various studies. Currently, there are eight species of the genus Hydnora; seven in Africa and one in the Arabian Peninsula. Notably, Hydnora abyssinica A.Br. and Hydnora africana Thunb. are widely distributed compared to other species. They are widely used for their medicinal and nutritional values. The information on ethnobotany, chemistry, pharmacology, and distribution of genus Hydnora was gathered using phytochemical and ethnobotanical books, electronic sources, and published articles. Preliminary phytochemical screening shows that flavonoids, phenolics, proanthocyanidins, and tannins are the main compounds in H. abyssinica and H. africana. Furthermore, 11 compounds have been isolated from H. abyssinica. The biological activities of H. abyssinica and H. africana have been reported. They include antibacterial, antiproliferative, antioxidant, antidiarrhea, and antifungal potentials. Despite the Hydnora species being practiced in ancient folkloric medicine, their traditional uses and pharmacological value are poorly documented. Based on the available information on ethnobotany, phytochemistry, pharmacology, and distribution, we aim to provide research gaps and challenges for a better understanding of this genus. This may be resourceful in the development of effective phytomedicines, and aid in conservation. The available studies on this genus on some aspects such as phytochemistry, pharmacological activities, and distribution are under-reported hence the need for further research.

Antioxidant and Antiproliferative Potentials of Ficus glumosa and Its Bioactive Polyphenol Metabolites.

Ficus glumosa Delile (Moraceae), a reputed plant that is used in herbal medicine, is of high medicinal and nutritional value in local communities primarily ascribed to its phytochemical profile. Currently, there are hardly any fine details on the chemical profiling and pharmacological evaluation of this species. In this study, the flavonoids and phenolics contents of the ethanol extracts and four extracted fractions (petroleum ether (PE), ethyl acetate (EA), n-butanol, and water) of the stem bark of Ficus glumosa were firstly quantified. Further, their antioxidant and antiproliferative potentials were also evaluated. The quantitative determination indicated that the EA and n-butanol fractions possessed the highest total flavonoids/phenolics levels of 274.05 ± 0.68 mg RE/g and 78.87 ± 0.97 mg GAE/g, respectively. Similarly, for the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and ferric-reducing antioxidant power (FRAP) assays, the EA fraction exhibited high potency in both DPPH and ABTS+ scavenging activities with IC50 values of 0.23 ± 0.03 mg/mL, 0.22 ± 0.03 mg/mL, and FRAP potential of 2.81 ± 0.01 mg Fe2+/g, respectively. Furthermore, the EA fraction displayed high cytotoxicity against human lung (A549) and colon (HT-29) cancer cells. Additionally, the liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) was employed in order to characterize the chemical constituents of the EA fraction of Ficus glumosa stem bark. Our findings revealed 16 compounds from the EA fraction that were possibly responsible for the strong antioxidant and anti-proliferative properties. This study provides edge-cutting background information on the exploitation of Ficus glumosa as a potential natural antioxidant and anti-cancer remedy.